Fig. 3From: KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteersDose-normalized individual values for Cmax and AUC0-inf of KH176 for the SAD and the MAD study. a. Dose normalized Cmax for the SAD study. b. Dose normalized AUC0-inf for the SAD study. c. Dose normalized Cmax for the MAD study. d. Dose normalized AUC0-inf for the MAD study. The horizontal lines depict the geometric mean value Back to article page